Toso controls encephalitogenic immune responses by dendritic cells and regulatory T cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 3, 2014, Pages 1060-1065

  Brenner, Dirk ^a,b   Brüstle, Anne ^a   Lin, Gloria H Y ^a   Lang, Philipp A ^a,c,d   Duncan, Gordon S ^a   Knobbe Thomsen, Christiane B ^a,d   Paul, Michael ST ^a,c   Reardon, Colin ^a,e   Tusche, Michael W ^a   Snow, Bryan ^a   Hamilton, Sara R ^a,c   Pfefferle, Aline ^a   Gilani, Syed O ^a   Ohashi, Pamela S ^a,c   Lang, Karl S ^f   Mak, Tak W ^a,c  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF TORONTO   (Canada)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^f UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Inflammation; Th1 Th17 cells

Indexed keywords

TOSO RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNITY; CELL DIFFERENTIATION; DENDRITIC CELL; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

INFLAMMATION; TH1/TH17 CELLS;

ANIMALS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINES; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS; TIME FACTORS;

EID: 84892931838     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1323166111     Document Type: Article

References (41)

1. Jacobson DL, Gange SJ, Rose NR, Graham NM (1997) Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84(3):223-243.
2. Littman DR, Rudensky AY (2010) Th17 and regulatory T cells in mediating and restraining inflammation. Cell 140(6):845-858.
3. Hitoshi Y, et al. (1998) Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells. Immunity 8(4):461-471.
4. Pallasch CP, et al. (2008) Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease. Blood 112(10):4213-4219.
5. Proto-Siqueira R, et al. (2008) SAGE analysis demonstrates increased expression of TOSO contributing to Fas-mediated resistance in CLL. Blood 112(2):394-397.
6. Nguyen XH, et al. (2012) Antiapoptotic function of Toso (Faim3) in death receptor signaling. Blood 119(7):1790-1791.
7. Shima H, et al. (2010) Identification of TOSO/FAIM3 as an Fc receptor for IgM. Int Immunol 22(3):149-156.
8. Kubagawa H, et al. (2009) Identity of the elusive IgM Fc receptor (FcmuR) in humans. J Exp Med 206(12):2779-2793.
9. Ouchida R, et al. (2012) Critical role of the IgM Fc receptor in IgM homeostasis, B-cell survival, and humoral immune responses. Proc Natl Acad Sci USA 109(40):E2699-E2706.
10. Choi SC, et al. (2013) Mouse IgM Fc receptor, FCMR, promotes B cell development and modulates antigen-driven immune responses. J Immunol 190(3):987-996.
11. Sigruener A, et al. (2007) E-LDL upregulates TOSO expression and enhances the survival of human macrophages. Biochem Biophys Res Commun 359(3):723-728.
12. Lang KS, et al. (2013) Involvement of Toso in activation of monocytes, macrophages, and granulocytes. Proc Natl Acad Sci USA 110(7):2593-2598.
13. Lang KS, et al. (2013) Reply to Honjo et al.: Functional relevant expression of Toso on granulocytes. Proc Natl Acad Sci USA 110(28):E2542-E2543.
14. Huitinga I, van Rooijen N, de Groot CJ, Uitdehaag BM, Dijkstra CD (1990) Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 172(4):1025-1033.
15. Ganguly D, Haak S, Sisirak V, Reizis B (2013) The role of dendritic cells in autoimmunity. Nat Rev Immunol 13(8):566-577.
16. Hawiger D, et al. (2001) Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 194(6):769-779.
17. Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH (2000) Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192 (9):1213-1222.
18. Garza KM, et al. (2000) Role of antigen-presenting cells in mediating tolerance and autoimmunity. J Exp Med 191(11):2021-2027.
19. Dissanayake D, et al. (2011) Nuclear factor-κB1 controls the functional maturation of dendritic cells and prevents the activation of autoreactive T cells. Nat Med 17(12):1663-1667.
20. Francisco LM, et al. (2009) PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med 206(13):3015-3029.
21. Huang C (2009) Receptor-Fc fusion therapeutics, traps, and MIMETIBODY technology. Curr Opin Biotechnol 20(6):692-699.
22. Peppel K, Crawford D, Beutler B (1991) A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity. J Exp Med 174(6):1483-1489.
23. Ducharme E, Weinberg JM (2008) Etanercept. Expert Opin Biol Ther 8(4):491-502.
24. Kantarci O, et al. Turkish Multiple Sclerosis Study Group (TUMSSG) (1998) Survival and predictors of disability in Turkish MS patients. Neurology 51(3):765-772.
25. Park H, et al. (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6(11):1133-1141.
26. Langrish CL, et al. (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201(2):233-240.
27. Croxford AL, Kurschus FC, Waisman A (2011) Mouse models for multiple sclerosis: Historical facts and future implications. Biochim Biophys Acta 1812(2):177-183.
28. Bettelli E, et al. (2004) Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J Exp Med 200(1):79-87.
29. Codarri L, et al. (2011) RORyt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat Immunol 12(6):560-567.
30. Mangan PR, et al. (2006) Transforming growth factor-beta induces development of the T (H) 17 lineage. Nature 441(7090):231-234.
31. Lutz MB, Schuler G (2002) Immature, semi-mature and fully mature dendritic cells: Which signals induce tolerance or immunity? Trends Immunol 23(9):445-449.
32. Kretschmer K, et al. (2005) Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6(12):1219-1227.
33. Yamazaki S, et al. (2008) CD8+CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J Immunol 181(10):6923-6933.
34. Yogev N, et al. (2012) Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor (+) regulatory T cells. Immunity 37(2):264-275.
35. Probst HC, McCoy K, Okazaki T, Honjo T, van den Broek M (2005) Resting dendritic cells induce peripheral CD8+T cell tolerance through PD-1 and CTLA-4. Nat Immunol 6(3):280-286.
36. Keir ME, Butte MJ, Freeman GJ, Sharpe AH (2008) PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 26:677-704.
37. Strober BE, Menon K (2007) Alefacept for the treatment of psoriasis and other dermatologic diseases. Dermatol Ther 20(4):270-276.
38. Hoffman HM, et al. (2008) Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies. Arthritis Rheum 58(8):2443-2452.
39. Posadas A, Lisse J, Sarkar S (2009) Abatacept in the treatment of rheumatoid arthritis. Expert Rev Clin Immunol 5(1):9-17.
40. Ohashi PS, et al. (1991) Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65(2):305-317.
41. Brüstle A, et al. (2012) The NF-kB regulator MALT1 determines the encephalitogenic potential of Th17 cells. J Clin Invest 122(12):4698-4709.